Cervical Cancer Diagnostics Development Services

Solutions

Online Inquiry

Name *

Email *

Phone *

Services Interested *

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

At Alfa Cytology, we are dedicated to advancing cervical cancer diagnostics through innovative and comprehensive services. Our approach includes targeted strategies in cancer biomarker discovery, imaging services, and multi-omics services.

Our Services

Cancer Biomarker Discovery

Our cancer biomarker discovery services focus on identifying novel biomarkers that can enhance the early detection and diagnosis of cervical cancer. Our services are structured around the following key areas:

Screening and Early Diagnosis

HPV DNA Typing: Identifying high-risk HPV strains associated with cervical cancer.
p16INK4a: A biomarker that helps in distinguishing between benign and premalignant lesions.
Methylation Markers: Utilizing specific DNA methylation patterns to improve diagnostic accuracy.

Prognostic Assessment

PD-L1: Evaluating the expression of this checkpoint protein to understand immune evasion in tumors.
Ki-67: A proliferation marker that aids in assessing tumor growth and aggressiveness.
Survivin: An inhibitor of apoptosis that can serve as an indicator of tumor prognosis.

Therapeutic Targets

PD-1/PD-L1: Targeting immune checkpoints to enhance anti-tumor immunity.
VEGF: Understanding tumor angiogenesis to inform treatment strategies.
PI3K/AKT Pathway: Identifying alterations that could present potential therapeutic targets.

Recurrence Monitoring

SCC-Ag: A serum marker for monitoring squamous cell carcinoma recurrence.
ctDNA: Utilizing circulating tumor DNA to detect minimal residual disease and monitor treatment response.

Imaging Services

In the realm of cervical cancer diagnostics, advanced imaging plays a critical role in accurate diagnosis and staging. Alfa Cytology offers state-of-the-art imaging services, including:

High-Resolution Imaging

Employing techniques such as digital pathology and fluorescence imaging to provide detailed visualization of cervical tissues, allowing for precise evaluation of dysplastic changes.

Machine Learning Integration

Utilizing AI-driven algorithms to assist pathologists in interpreting imaging results, enhancing diagnostic accuracy and efficiency.

Quantitative Imaging Analysis

Providing quantitative assessments that can reveal critical insights into tumor behavior and treatment responses, facilitating better clinical decision-making.

Multi-omics Services

Our Multi-omics Services integrate various omic technologies—genomics, transcriptomics, proteomics, and metabolomics—to provide a holistic understanding of cervical cancer. By analyzing data from multiple layers of biological information, we can:

Identify molecular signatures specific to cervical cancer initiation and progression.
Discover potential therapeutic targets that can inform treatment strategies.
Monitor disease progression and treatment response through continuous profiling of patient samples.

Alfa Cytology is your ideal partner in cervical cancer diagnostics, leveraging our expertise in oncology. We provide tailored services in Cancer Biomarker Discovery, Imaging, and Multi-omics to meet your needs. From research solutions to detailed reports, we offer comprehensive support. For inquiries or custom services, please contact us.

For research use only.